Agree with you, Abobo.
It's expected that more cases of Tami resistant will be anounced in the comming weeks. By that time, WHO and all the governments will ask GSK to increase its production, or licence to other Medical companies to produce it. On the other hand, all the parties will ask about the progress of LANI. It's interesting situation for BTA/GSK, especially for GSK that they don't know how good their product Relenza is, while the rest of the world desperately want it.
- Forums
- ASX - By Stock
- BTA
- tamiflu resistant from hong kong more worring
tamiflu resistant from hong kong more worring, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)